SWK Holdings Corporation (NASDAQ:SWKH) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET

Company Participants

Jason Rando - Tiberend Strategic Advisors

Winston Black - Chairman and CEO

Conference Call Participants

Kyle Bauser - Lake Street Capital Markets

Operator

Good morning, and welcome to the SWK Holdings Corporation Second Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Jason Rando, Tiberend Strategic Advisors. Please go ahead.

Jason Rando

Thank you, and good morning, everyone, and welcome to the SWK Holdings Second Quarter 2022 Financial and Corporate Results Call.

After market closed yesterday, SWK Holdings issued a press release detailing its financial results for the 3 months ended June 30, 2022. The press release can be found in the Investor Relations section of swkhold.com other news releases.

Before beginning today's call, I would like to make the following statement regarding forward-looking statements. Today, we'll be making certain forward-looking statements about future expectations, plans, events and circumstances, including statements about our strategy, future operations and the development of consumer and drug product candidates. Financial future potential product candidates and studies and our expectations regarding capital allocation and cash resources.

These statements are based on current expectations. You should not place undue reliance on these statements. Actual results may differ materially due to our risks and uncertainties, including those detailed in the Risk Factors section of SWK Holdings 10-K filed with the SEC and other filings we make with the SEC from time to time. SWK Holdings disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or otherwise.

Joining me on today's call is Winston Black, Chairman and CEO of SWK Holdings, who will provide an update on the SWK's second quarter and first half of 2022 corporate and financial results.

Winston, go ahead.

Winston Black

Thank you, Jason. Thanks, everyone, for joining our second quarter conference call. As we celebrate our 10th anniversary as a life science focused specialty finance company, catering to small- and mid-sized commercial stage companies.

Before I discuss our second quarter results. I'd like to take a moment to thank our employees, Board of Directors, shareholders and partner companies for the support given to our leadership team as we built SWK to be a partner of choice for small- to mid-sized life science companies seeking non-dilutive financing to fuel the development and the commercialization of life-saving and life-enhancing technologies.